These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 38558495)

  • 21. PRAME immunohistochemistry as an adjunct for diagnosis and histological margin assessment in lentigo maligna.
    Gradecki SE; Valdes-Rodriguez R; Wick MR; Gru AA
    Histopathology; 2021 Jun; 78(7):1000-1008. PubMed ID: 33280156
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Preferentially Expressed Antigen in Melanoma Immunostaining in a Series of Melanocytic Neoplasms.
    Googe PB; Flanigan KL; Miedema JR
    Am J Dermatopathol; 2021 Nov; 43(11):794-800. PubMed ID: 33989214
    [TBL] [Abstract][Full Text] [Related]  

  • 23. PRAME expression in 155 cases of metastatic melanoma.
    Gradecki SE; Slingluff CL; Gru AA
    J Cutan Pathol; 2021 Apr; 48(4):479-485. PubMed ID: 32939793
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The utility of PRAME staining in identifying malignant transformation of melanocytic nevi.
    Lohman ME; Steen AJ; Grekin RC; North JP
    J Cutan Pathol; 2021 Jul; 48(7):856-862. PubMed ID: 33433032
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Potential diagnostic utility of PRAME and p16 immunohistochemistry in melanocytic nevi and malignant melanoma.
    Bahmad HF; Oh KS; Alexis J
    J Cutan Pathol; 2023 Aug; 50(8):763-772. PubMed ID: 37114299
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The diagnostic utility of PRAME and p16 in distinguishing nodal nevi from nodal metastatic melanoma.
    See SHC; Finkelman BS; Yeldandi AV
    Pathol Res Pract; 2020 Sep; 216(9):153105. PubMed ID: 32825968
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Characterization of PRAME immunohistochemistry reveals lower expression in pediatric melanoma compared to adult melanoma.
    Forchhammer S; Aebischer V; Lenders D; Seitz CM; Schroeder C; Liebmann A; Abele M; Wild H; Bien E; Krawczyk M; Schneider DT; Brecht IB; Flatz L; Hahn M
    Pigment Cell Melanoma Res; 2024 Jul; 37(4):453-461. PubMed ID: 38509752
    [TBL] [Abstract][Full Text] [Related]  

  • 28. PRAME Expression Correlates With Genomic Aberration and Malignant Diagnosis of Spitzoid Melanocytic Neoplasms.
    Gerami P; Benton S; Zhao J; Zhang B; Lampley N; Roth A; Boutko A; Olivares S; Busam KJ
    Am J Dermatopathol; 2022 Aug; 44(8):575-580. PubMed ID: 35503885
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Preferentially expressed antigen in melanoma and p16 expression in acral melanocytic neoplasms.
    McBride JD; McAfee JL; Piliang M; Bergfeld WF; Fernandez AP; Ronen S; Billings SD; Ko JS
    J Cutan Pathol; 2022 Mar; 49(3):220-230. PubMed ID: 34476825
    [TBL] [Abstract][Full Text] [Related]  

  • 30. PRAME Expression in Melanocytic Tumors.
    Lezcano C; Jungbluth AA; Nehal KS; Hollmann TJ; Busam KJ
    Am J Surg Pathol; 2018 Nov; 42(11):1456-1465. PubMed ID: 30045064
    [TBL] [Abstract][Full Text] [Related]  

  • 31. PRAME expression in melanocytic lesions of the nail.
    Parra O; Linos K; Li Z; Yan S
    J Cutan Pathol; 2022 Jul; 49(7):610-617. PubMed ID: 35294053
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Pitfalls of PRAME Immunohistochemistry in a Large Series of Melanocytic and Nonmelanocytic Lesions With Literature Review.
    Turner N; Ko CJ; McNiff JM; Galan A
    Am J Dermatopathol; 2024 Jan; 46(1):21-30. PubMed ID: 37982498
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Diagnostic utility of PRAME expression by immunohistochemistry in subungual and non-subungual acral melanocytic lesions.
    Rothrock AT; Torres-Cabala CA; Milton DR; Cho WC; Nagarajan P; Vanderbeck K; Curry JL; Ivan D; Prieto VG; Aung PP
    J Cutan Pathol; 2022 Oct; 49(10):859-867. PubMed ID: 35794643
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Preferentially expressed antigen in melanoma expression in nonmelanoma skin cancers and melanocytes in surrounding skin.
    Elsensohn A; Hanson J; Ferringer T
    J Cutan Pathol; 2021 Sep; 48(9):1150-1155. PubMed ID: 33719089
    [TBL] [Abstract][Full Text] [Related]  

  • 35. PRAME expression in spindle cell melanoma, malignant peripheral nerve sheath tumour, and other cutaneous sarcomatoid neoplasms: a comparative analysis.
    Hrycaj SM; Szczepanski JM; Zhao L; Siddiqui J; Thomas DG; Lucas DR; Patel RM; Harms PW; Bresler SC; Chan MP
    Histopathology; 2022 Dec; 81(6):818-825. PubMed ID: 36102613
    [TBL] [Abstract][Full Text] [Related]  

  • 36. PRAME Immunohistochemistry as an Ancillary Test for the Assessment of Melanocytic Lesions.
    Lezcano C; Jungbluth AA; Busam KJ
    Surg Pathol Clin; 2021 Jun; 14(2):165-175. PubMed ID: 34023098
    [TBL] [Abstract][Full Text] [Related]  

  • 37. PRAME immunohistochemistry in soft tissue tumors and mimics: a study of 350 cases highlighting its imperfect specificity but potentially useful diagnostic applications.
    Cammareri C; Beltzung F; Michal M; Vanhersecke L; Coindre JM; Velasco V; Le Loarer F; Vergier B; Perret R
    Virchows Arch; 2023 Aug; 483(2):145-156. PubMed ID: 37477762
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Staged Excision of Lentigo Maligna of the Head and Neck: Assessing Surgical Excision Margins With Melan A, SOX10, and PRAME Immunohistochemistry.
    de Wet J; Plessis PJD; Schneider JW
    Am J Dermatopathol; 2023 Feb; 45(2):107-112. PubMed ID: 36669074
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The Expression of PRAME as an Aid for Diagnosis and Evaluation of Histologic Margins of Intraepidermal Cutaneous Melanoma in Xeroderma Pigmentosum Patients.
    Ferreira LÁ; Kim EHJ; Stelini RF; Velho PENF; de Moraes AM; Buffo T; Cintra ML
    Appl Immunohistochem Mol Morphol; 2024 Jul; 32(6):272-279. PubMed ID: 38860582
    [TBL] [Abstract][Full Text] [Related]  

  • 40. PRAME expression by immunohistochemistry and reverse transcription quantitative PCR in conjunctival melanocytic lesions-a comprehensive clinicopathologic study of 202 cases and correlation of cytogenetics with PRAME expression in challenging conjunctival melanocytic lesions.
    Mudhar HS; Milman T; Stevenson S; Watson M; Kim J; Magan T; Salvi SM; Harley U; Lally SE; Shields CL
    Hum Pathol; 2023 Apr; 134():1-18. PubMed ID: 36804828
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.